Recent Quotes (30 days)

You have no recent quotes
chg | %

Medmira Inc  

(Public, CVE:MIR)   Watch this stock  
Find more results for MIR
+0.0050 (14.29%)
Delayed:   9:30AM EDT
CVE data delayed by 15 mins - Disclaimer
Currency in CAD
Range 0.04 - 0.04
52 week 0.04 - 0.10
Open 0.04
Vol / Avg. 6,287.00/18,075.00
Mkt cap 23.04M
P/E     -
Div/yield     -
EPS 0.00
Shares 658.36M
Beta 0.34
Inst. own     -
May 27, 2016
Q3 2016 MedMira Inc Earnings Release (Estimated) Add to calendar
Mar 24, 2016
Q2 2016 MedMira Inc Earnings Release

Key stats and ratios

Q1 (Jan '16) 2015
Net profit margin -71.65% -79.70%
Operating margin -59.51% -60.99%
EBITD margin - -58.67%
Return on average assets -91.46% -178.15%
Return on average equity - -
Employees 65 -
CDP Score - -


Suite 1, 155 Chain Lake Dr
+1-902-4501588 (Phone)
+1-902-4501580 (Fax)

Website links


MedMira Inc is a Canada-based developer, manufacturer and marketer of diagnostics. The Company develops, manufactures, licenses and market testing solutions. The Company’s tests include HIV, which is suited for a range of testing environments from the point-of-care to the laboratory. Testing applications for Reveal HIV include public health programs, voluntary testing and counselling centers, pharmacies, physician offices, immigration screening, occupational exposures, and care clinics; Helicobacter pylori (HP), which detects HP antibodies in serum, plasma or whole blood produced in response to HP infection. Reveal Rapid Syphilis Antibody Test, which detects Treponema Pallidum (TP) antibodies in serum, plasma or whole blood.

Officers and directors

Marvyn Robar Independent Chairman of the Board
Hermes Chan Chief Executive Officer, Director
Markus M. Meile Chief Financial Officer
Sing Chan Chief Operating Officer
Robyn Cook Chief Corporate Officer, Corporate Secretary
Philippe Dro M.D. Director
Age: 48
Romano Robusto Independent Director